Re-Thinking Clinical Trials in Oncology
 Assessing the landscape of novel trial design for cancer therapies to improve data collection, enhance patient access, and drive clinical outcomes for breakthrough therapies

October 28, 2020 | Live Virtual Forum (EST)
View Program
Vendor Registration

Laurie Smaldone MD

CMO/CSO NDA Group

WEDNESDAY, OCTOBER 28

11:15 AM Early Development & Regulatory Strategy in Oncology :What’s Important to Get New Products Approved?

What do you need to think about early in development to get new products approve? In a very condensed time frame for oncology products, understand why you need think “end game” early on.

In Partnership With :

IQPC Corporate

QUESTIONS?
Contact us: 1-800-882-8684
Email: enquiry@iqpc.com

Iqpc Icon

©2024 IQPC. All rights reserved.